TargetMol’s well-known-marketing and advertising inhibitors for your personalized assortment.
Vemurafenib (PLX4032, RG7204) is truly a groundbreaking and strong inhibitor of B-RafV600E with IC50 of 31 nM.
Olaparib (AZD2281, KU0059436) is truly a fussy inhibitor of PARP1/2 with IC50 of 5 nM/1 nM, 300-conditions less effective against tankyrase-1. Time 3.
Rapamycin (Sirolimus, AY-22989, WY-090217) is actually a distinct mTOR inhibitor with IC50 of ~.1 nM.
4. Ibrutinib (PCI-32765)
Ibrutinib (PCI-32765) could be a potent and highly choosy Brutons tyrosine kinase (Btk) inhibitor with IC50 of .5 nM, modestly highly effective to Bmx, CSK, FGR, BRK, HCK, significantly less successful to EGFR, Confident, ErbB2, JAK3, and others.
Trametinib (GSK1120212) might be a highly a number of and powerful MEK1/2 inhibitor with IC50 of .92 nM/1.8 nM, no inhibition in the kinase actions of c-Raf, B-Raf, ERK1/2.
TargetMol is headquartered in Boston, Massachusetts. Our significant products are molecular libraries and inhibitors, which includes over 4000 bioactive factors. Our components bring mobile sending transduction tests, cellphone inducing inspections, product or service repositioning, and advantageous managing assessments.
Goal Molecule Corp.
Cope with: 1 Boston Condition, Series 2600, Boston, Massachusetts, 02108